Director · Pyxis Oncology, Inc. · Pyxis Oncology, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
34.5K
Price
—
Executed
Nov 6, 2026
Disclosed
Nov 6, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 6, 2026 disclosed
PYXS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · PYXS
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Pyxis Oncology, Inc. — Stock Option (Right to Buy)
Ticker
PYXS
Shares
34.5K
Price per share
$0
Execution date (reported)
Nov 6, 2026
Owned after transaction
34.5K shares
Days from execution to publication
0
What this establishes
Humphrey Rachel filed this Form 4 reporting a grant or award of PYXS on Nov 6, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Humphrey Rachelcik:0001579781
Issuer
Pyxis Oncology, Inc.cik:0001782223
Revision history · 0
No field has changed since this record was first ingested.
